iGlucose® Cellular RPM™ Shown Efficacious for Managing Diabetes Mellitus During Pregnancy
A recently published research study from the University of Arkansas for Medical Sciences concluded that using cellular-enabled RPM™ glucose meters is valuable in managing Type 1 diabetes mellitus and Type 2 diabetes mellitus during pregnancy.
- A recently published research study from the University of Arkansas for Medical Sciences concluded that using cellular-enabled RPM™ glucose meters is valuable in managing Type 1 diabetes mellitus and Type 2 diabetes mellitus during pregnancy.
- Participants who used the iGlucose® glucose meter demonstrated increased positive appraisal of diabetes and general life satisfaction.
- In addition, participants scored the cellular RPM™ iGlucose® device high on both system usability and satisfaction.
- The overall feedback on the iGlucose® glucose meter, the gold standard in cellular RPM™ glucose meters since receiving FDA approval in 2016, was positive across multiple evaluation points.